| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.833 | 0.004 | 0.833 | Hypolipemic | 0.81 0.004 DBMET00351 0.792 0.004 DBMET00352 0.833 0.004 DBMET01268 0.81 0.004 DBMET01266 0.661 0.005 DBMET02422 0.792 0.004 DBMET01267 0.629 0.005 DBMET02423 | ||
| 0.547 | 0.005 | 0.55 | NOS3 expression enhancer | 0.55 0.005 DBMET00351 0.469 0.005 DBMET00352 0.547 0.005 DBMET01268 0.55 0.005 DBMET01266 0.502 0.005 DBMET02422 0.469 0.005 DBMET01267 0.434 0.007 DBMET02423 | DBMET01266 | |
| 0.418 | 0.004 | 0.438 | Cholesterol synthesis inhibitor | 0.438 0.003 DBMET00351 0.396 0.004 DBMET00352 0.418 0.004 DBMET01268 0.438 0.003 DBMET01266 0.214 0.024 DBMET02422 0.396 0.004 DBMET01267 0.163 0.038 DBMET02423 | DBMET01266 | |
| 0.342 | 0.001 | 0.342 | HMG CoA reductase inhibitor | 0.252 0.001 DBMET00351 0.273 0.001 DBMET00352 0.342 0.001 DBMET01268 0.252 0.001 DBMET01266 0.106 0.002 DBMET02422 0.273 0.001 DBMET01267 0.108 0.002 DBMET02423 | ||
| 0.302 | 0.015 | 0.311 | Insulin sensitizer | 0.311 0.014 DBMET00351 0.256 0.031 DBMET00352 0.302 0.015 DBMET01268 0.311 0.014 DBMET01266 0.152 0.131 DBMET02422 0.256 0.031 DBMET01267 | DBMET01266 | |
| 0.288 | 0.054 | 0.288 | Interleukin agonist | 0.267 0.067 DBMET00351 0.288 0.054 DBMET01268 0.267 0.067 DBMET01266 0.211 0.111 DBMET02422 | ||
| 0.279 | 0.06 | 0.279 | Platelet antagonist | 0.252 0.071 DBMET00351 0.181 0.117 DBMET00352 0.279 0.06 DBMET01268 0.252 0.071 DBMET01266 0.192 0.107 DBMET02422 0.181 0.117 DBMET01267 | ||
| 0.274 | 0.094 | 0.378 | Interleukin 2 agonist | 0.28 0.089 DBMET00351 0.245 0.125 DBMET00352 0.274 0.094 DBMET01268 0.28 0.089 DBMET01266 0.378 0.034 DBMET02422 0.245 0.125 DBMET01267 0.361 0.041 DBMET02423 | DBMET02422 | |
| 0.322 | 0.144 | 0.401 | Cyclophilin D inhibitor | 0.319 0.146 DBMET00351 0.322 0.144 DBMET01268 0.319 0.146 DBMET01266 0.401 0.09 DBMET02422 0.259 0.202 DBMET02423 | DBMET02422 | |
| 0.266 | 0.112 | 0.3 | Sodium/bile acid cotransporter inhibitor | 0.3 0.079 DBMET00351 0.273 0.105 DBMET00352 0.266 0.112 DBMET01268 0.3 0.079 DBMET01266 0.273 0.105 DBMET01267 | DBMET01266 | |
| 0.15 | 0.01 | 0.15 | Prostaglandin EP2 antagonist | 0.136 0.011 DBMET00351 0.12 0.014 DBMET00352 0.15 0.01 DBMET01268 0.136 0.011 DBMET01266 0.066 0.036 DBMET02422 0.12 0.014 DBMET01267 0.055 0.046 DBMET02423 | ||
| 0.126 | 0.011 | 0.126 | Sphingosine 1-phosphate receptor antagonist | 0.12 0.013 DBMET00351 0.126 0.011 DBMET01268 0.12 0.013 DBMET01266 | ||
| 0.254 | 0.144 | 0.357 | Immunosuppressant | 0.253 0.145 DBMET00351 0.254 0.144 DBMET01268 0.253 0.145 DBMET01266 0.357 0.083 DBMET02422 0.274 0.132 DBMET02423 | DBMET02422 | |
| 0.111 | 0.008 | 0.111 | Prostaglandin F2 alpha antagonist | 0.106 0.009 DBMET00351 0.091 0.016 DBMET00352 0.111 0.008 DBMET01268 0.106 0.009 DBMET01266 0.064 0.039 DBMET02422 0.091 0.016 DBMET01267 | ||
| 0.108 | 0.006 | 0.108 | Sphingosine 1-phosphate receptor 3 antagonist | 0.104 0.007 DBMET00351 0.108 0.006 DBMET01268 0.104 0.007 DBMET01266 | ||
| 0.198 | 0.111 | 0.253 | Tumour necrosis factor alpha release inhibitor | 0.201 0.108 DBMET00351 0.198 0.111 DBMET01268 0.201 0.108 DBMET01266 0.253 0.073 DBMET02422 0.164 0.14 DBMET02423 | DBMET02422 | |
| 0.163 | 0.077 | 0.176 | Growth hormone agonist | 0.176 0.07 DBMET00351 0.163 0.077 DBMET01268 0.176 0.07 DBMET01266 | DBMET01266 | |
| 0.085 | 0.021 | 0.085 | Prostaglandin antagonist | 0.062 0.031 DBMET00351 0.085 0.021 DBMET01268 0.062 0.031 DBMET01266 | ||
| 0.082 | 0.02 | 0.082 | Nitric oxide donor | 0.078 0.024 DBMET00351 0.07 0.032 DBMET00352 0.082 0.02 DBMET01268 0.078 0.024 DBMET01266 0.077 0.025 DBMET02422 0.07 0.032 DBMET01267 0.071 0.031 DBMET02423 | ||
| 0.168 | 0.108 | 0.168 | Platelet aggregation inhibitor | 0.143 0.137 DBMET00351 0.168 0.108 DBMET01268 0.143 0.137 DBMET01266 | ||
| 0.102 | 0.045 | 0.11 | Bile acid receptor antagonist | 0.11 0.031 DBMET00351 0.102 0.045 DBMET01268 0.11 0.031 DBMET01266 | DBMET01266 | |
| 0.158 | 0.106 | 0.16 | P-glycoprotein inhibitor | 0.16 0.101 DBMET00351 0.158 0.106 DBMET01268 0.16 0.101 DBMET01266 | DBMET01266 | |
| 0.094 | 0.05 | 0.094 | ATPase (Vacuolar H+) inhibitor | 0.094 0.049 DBMET00351 0.094 0.05 DBMET01268 0.094 0.049 DBMET01266 0.094 0.049 DBMET02422 0.082 0.074 DBMET02423 | ||
| 0.063 | 0.023 | 0.064 | Leukotriene C antagonist | 0.064 0.021 DBMET00351 0.063 0.023 DBMET01268 0.064 0.021 DBMET01266 | DBMET01266 | |
| 0.147 | 0.109 | 0.227 | Platelet adhesion inhibitor | 0.155 0.101 DBMET00351 0.147 0.109 DBMET01268 0.155 0.101 DBMET01266 0.227 0.058 DBMET02422 0.161 0.095 DBMET02423 | DBMET02422 | |
| 0.062 | 0.026 | 0.062 | Sphingosine 1-phosphate receptor 1 antagonist | 0.058 0.032 DBMET00351 0.062 0.026 DBMET01268 0.058 0.032 DBMET01266 | ||
| 0.102 | 0.066 | 0.137 | Toll-Like receptor 4 antagonist | 0.113 0.051 DBMET00351 0.094 0.081 DBMET00352 0.102 0.066 DBMET01268 0.113 0.051 DBMET01266 0.137 0.029 DBMET02422 0.094 0.081 DBMET01267 0.124 0.04 DBMET02423 | DBMET02422 | |
| 0.126 | 0.091 | 0.142 | Farnesoid X receptor antagonist | 0.142 0.062 DBMET00351 0.126 0.091 DBMET01268 0.142 0.062 DBMET01266 | DBMET01266 | |
| 0.129 | 0.097 | 0.129 | MAP3K9 inhibitor | 0.127 0.1 DBMET00351 0.129 0.097 DBMET01268 0.127 0.1 DBMET01266 | ||
| 0.127 | 0.1 | 0.127 | Insulin secretagoues | 0.127 0.1 DBMET00351 0.127 0.1 DBMET01268 0.127 0.1 DBMET01266 0.122 0.108 DBMET02422 | ||
| 0.142 | 0.117 | 0.142 | Lipocortins synthesis antagonist | 0.135 0.13 DBMET00351 0.135 0.13 DBMET00352 0.142 0.117 DBMET01268 0.135 0.13 DBMET01266 0.135 0.13 DBMET01267 | ||
| 0.142 | 0.116 | 0.144 | ATPase inhibitor | 0.144 0.112 DBMET00351 0.142 0.116 DBMET01268 0.144 0.112 DBMET01266 | DBMET01266 | |
| 0.197 | 0.172 | 0.4 | Transcription factor NF kappa B inhibitor | 0.27 0.113 DBMET00351 0.197 0.172 DBMET01268 0.27 0.113 DBMET01266 0.4 0.064 DBMET02422 0.208 0.161 DBMET02423 | DBMET02422 | |
| 0.06 | 0.04 | 0.06 | Cathepsin E inhibitor | 0.057 0.045 DBMET00351 0.056 0.047 DBMET00352 0.06 0.04 DBMET01268 0.057 0.045 DBMET01266 0.056 0.047 DBMET01267 | ||
| 0.126 | 0.107 | 0.135 | Phospholipase A2 inhibitor | 0.135 0.092 DBMET00351 0.126 0.107 DBMET01268 0.135 0.092 DBMET01266 | DBMET01266 | |
| 0.041 | 0.022 | 0.041 | Leukotriene C4 antagonist | 0.041 0.021 DBMET00351 0.041 0.022 DBMET01268 0.041 0.021 DBMET01266 | ||
| 0.19 | 0.172 | 0.19 | Nootropic | 0.19 0.172 DBMET01268 | ||
| 0.112 | 0.094 | 0.127 | Bone formation stimulant | 0.127 0.079 DBMET00351 0.112 0.094 DBMET01268 0.127 0.079 DBMET01266 | DBMET01266 | |
| 0.029 | 0.016 | 0.029 | Prostaglandin EP4 antagonist | 0.029 0.016 DBMET01268 | ||
| 0.038 | 0.032 | 0.038 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.032 DBMET01268 | ||
| 0.09 | 0.087 | 0.09 | Folate antagonist | 0.09 0.087 DBMET01268 | ||
| 0.022 | 0.036 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.023 DBMET02422 | DBMET02422 | |
| 0.024 | 0.039 | 0.029 | ATP citrate lysase inhibitor | 0.029 0.027 DBMET00351 0.029 0.027 DBMET01266 | DBMET01266 | |
| 0.129 | 0.165 | 0.145 | Catenin beta inhibitor | 0.145 0.119 DBMET00351 0.145 0.119 DBMET01266 | DBMET01266 | |
| 0.088 | 0.127 | 0.118 | Toll-Like receptor 2 antagonist | 0.118 0.08 DBMET00351 0.118 0.08 DBMET01266 | DBMET01266 | |
| 0.102 | 0.143 | 0.116 | Papain-like protease (SARS coronavirus) inhibitor | 0.116 0.092 DBMET00351 0.116 0.092 DBMET01266 | DBMET01266 | |
| 0.052 | 0.097 | 0.067 | HIV-1 integrase inhibitor | 0.067 0.054 DBMET00352 0.067 0.054 DBMET01267 | DBMET01267 | |
| 0.044 | 0.093 | 0.054 | Adenine nucleotide translocase inhibitor | 0.054 0.044 DBMET02422 | DBMET02422 | |
| 0.038 | 0.089 | 0.053 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.053 0.048 DBMET00351 0.053 0.048 DBMET01266 | DBMET01266 | |
| 0.166 | 0.227 | 0.234 | Antithrombotic | 0.234 0.139 DBMET02422 | DBMET02422 | |
| 0.106 | 0.178 | 0.135 | Interleukin antagonist | 0.135 0.13 DBMET00351 0.135 0.13 DBMET01266 | DBMET01266 | |
| 0.098 | 0.182 | 0.216 | Nitric oxide antagonist | 0.216 0.062 DBMET02422 0.202 0.067 DBMET02423 | DBMET02422 | |
| 0.186 | 0.296 | 0.491 | Apoptosis agonist | 0.237 0.229 DBMET00351 0.237 0.229 DBMET01266 0.491 0.077 DBMET02422 0.396 0.116 DBMET02423 | DBMET02422 | |
| 0.153 | 0.265 | 0.328 | Apoptosis antagonist | 0.328 0.067 DBMET02422 0.298 0.087 DBMET02423 | DBMET02422 | |
| 0.078 | 0.19 | 0.365 | Angiogenesis stimulant | 0.365 0.029 DBMET02422 0.352 0.032 DBMET02423 | DBMET02422 | |
| 0.108 | 0.232 | 0.21 | Vasodilator | 0.21 0.097 DBMET02422 0.167 0.135 DBMET02423 | DBMET02422 | |
| 0.113 | 0.25 | 0.274 | Hypoglycemic | 0.274 0.063 DBMET02422 0.23 0.09 DBMET02423 | DBMET02422 | |
| 0.091 | 0.24 | 0.173 | Immunostimulant | 0.173 0.137 DBMET02422 | DBMET02422 | |
| 0.081 | 0.24 | 0.217 | Hepatoprotectant | 0.217 0.056 DBMET02422 0.199 0.065 DBMET02423 | DBMET02422 | |
| 0.025 | 0.19 | 0.061 | Heparanase inhibitor | 0.061 0.022 DBMET02422 | DBMET02422 | |
| 0.124 | 0.289 | 0.268 | Peptidyltransferase inhibitor | 0.268 0.039 DBMET02422 0.245 0.054 DBMET02423 | DBMET02422 | |
| 0.182 | 0.36 | 0.424 | Antiinflammatory | 0.424 0.125 DBMET02422 0.289 0.225 DBMET02423 | DBMET02422 | |
| 0.037 | 0.235 | 0.107 | Topoisomerase II inhibitor | 0.107 0.079 DBMET02422 | DBMET02422 | |
| 0.114 | 0.317 | 0.211 | Immunomodulator | 0.211 0.151 DBMET02422 | DBMET02422 | |
| 0.03 | 0.234 | 0.102 | Topoisomerase I inhibitor | 0.102 0.068 DBMET02422 | DBMET02422 | |
| 0.016 | 0.243 | 0.052 | Protein 50S ribosomal subunit inhibitor | 0.051 0.039 DBMET02422 0.052 0.038 DBMET02423 | DBMET02423 | |
| 0.014 | 0.275 | 0.148 | Selectin antagonist | 0.148 0.018 DBMET02422 0.121 0.022 DBMET02423 | DBMET02422 | |
| 0.01 | 0.272 | 0.107 | Antineoplastic antibiotic | 0.107 0.043 DBMET02422 0.104 0.044 DBMET02423 | DBMET02422 | |
| 0.015 | 0.304 | 0.043 | Antibiotic Aminoglycoside-like | 0.043 0.018 DBMET02422 0.042 0.019 DBMET02423 | DBMET02422 | |
| 0.049 | 0.341 | 0.246 | Histone deacetylase SIRT1 inhibitor | 0.203 0.029 DBMET02422 0.246 0.018 DBMET02423 | DBMET02423 | |
| 0.063 | 0.368 | 0.275 | Antioxidant | 0.275 0.072 DBMET02422 0.273 0.072 DBMET02423 | DBMET02422 | |
| 0.026 | 0.382 | 0.117 | Histone deacetylase class III inhibitor | 0.108 0.081 DBMET02422 0.117 0.073 DBMET02423 | DBMET02423 | |
| 0.016 | 0.388 | 0.114 | Sirtuin 1 inhibitor | 0.114 0.016 DBMET02422 0.114 0.016 DBMET02423 | DBMET02423 | |
| 0.016 | 0.606 | 0.192 | Free radical scavenger | 0.192 0.104 DBMET02422 0.192 0.104 DBMET02423 | DBMET02423 | |
| 0.028 | 0.665 | 0.309 | Antibacterial | 0.309 0.128 DBMET02422 0.279 0.151 DBMET02423 | DBMET02422 | |
| 0.004 | 0.743 | 0.047 | Phosphodiesterase 4A inhibitor | 0.047 0.037 DBMET00352 0.047 0.037 DBMET01267 | DBMET01267 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |